Lumena Pharmaceuticals, Inc.
Biomedical therapeutics and drug candidates developed through innovative pharmaceutical design
- Sector
- Biotech
- Headquarters
- San Diego, CA
- Founded
- 2011
- Latest Form D
- $45.5M, Mar 2014
- Total capital
- $45.7M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $45.7M
- 2 Form D · last Mar 2014
- 151 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 18 pending · first 2019
- Rank in peer group#481 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$45.5M
- Private capital raisedForm D · SEC · 1st filing$250K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Alana B. McNultyExecutive OfficerNamed in SEC Form D filings
- Alejandro B. DorenbaumExecutive OfficerNamed in SEC Form D filings
- Bradley T. KellerExecutive OfficerNamed in SEC Form D filings
- Ciara B. KennedyExecutive OfficerNamed in SEC Form D filings
- David R. SavelloDirectorNamed in SEC Form D filings
- Edward E. GreeneDirectorNamed in SEC Form D filings
Show all 15 people
- Edward R. MathersDirectorNamed in SEC Form D filings
- Ford S. WorthyExecutive OfficerNamed in SEC Form D filings
- Howard E. GreeneDirectorNamed in SEC Form D filings
- John E. McKearnDirectorNamed in SEC Form D filings
- Michael GreyExecutive Officer, DirectorNamed in SEC Form D filings
- Robert P. AlexanderDirectorNamed in SEC Form D filings
- Rosina S. Maar PaviaDirectorNamed in SEC Form D filings
- Susan E. DubeExecutive OfficerNamed in SEC Form D filings
- Ted S. GreeneDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 19- PendingBile Acid Recycling Inhibitors For Treatment Of Hypercholemia And Cholestatic Liver DiseaseUSPTOApplication 16696196
- PendingBile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver DiseasesUSPTOApplication 16679894
- GrantedBile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver DiseasesUSPTOUS 10,512,657
Show all 19 patent records
- Bile Acid Recycling Inhibitors For Treatment Of Hypercholemia And Cholestatic Liver DiseaseJul 2, 2020 · Application 16696196Pending
- Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver DiseasesMar 5, 2020 · Application 16679894Pending
- Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver DiseasesDec 24, 2019 · US 10,512,657Granted
- Bile Acid Recycling Inhibitors For Treatment Of Gastrointestinal InfectionsApr 30, 2015 · Application 14525806Pending
- Bile Acid Recycling Inhibitors For Treatment Of Hypercholemia And Cholestatic Liver DiseaseOct 30, 2014 · Application 14354553Pending
- Bile Acid Recycling Inhibitors For Treatment Of Primary Sclerosing Cholangitis And Inflammatory Bowel DiseaseSep 18, 2014 · Application 14212428Pending
- Bile Acid Recycling Inhibitors For Treatment Of Barrett's Esophagus And Gastroesophageal Reflux DiseaseSep 18, 2014 · Application 14213225Pending
- Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver DiseasesAug 28, 2014 · Application 14354548Pending
- Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver DiseasesDec 19, 2013 · Application 13866906Pending
- Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver DiseaseMay 2, 2013 · Application 13662283Pending
- Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver DiseasesMay 2, 2013 · Application 13662387Pending
- Bile Acid Recycling Inhibitors For Treatment Of PancreatitisApplication PCTUS2012049637Pending
- Bile Acid Recycling Inhibitors For Treatment Of Barrett's Esophagus And Gastroesophageal Reflux DiseaseApplication PCTUS2014028910Pending
- Bile Acid Recycling Inhibitors For Treatment Of Primary Sclerosing Cholangitis And Inflammatory Bowel DiseaseApplication PCTUS2014029151Pending
- Bile Acid Recycling Inhibitors For Treatment Of Gastrointestinal InfectionsApplication 61897083Pending
- Bile Acid Recycling Inhibitors for Treatment of Barrett's Esophagus and Gastroesophageal Reflux DiseaseApplication 61798876Pending
- Bile Acid Recycling Inhibitors for Treatment of Primary Sclerosing Cholangitis and Inflammatory Bowel DiseaseApplication 61798605Pending
- Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver DiseasesApplication PCTUS2012062284Pending
- Bile Acid Recycling Inhibitors For Treatment Of Hypercholemia And Cholestatic Liver DiseaseApplication PCTUS2012062303Pending
Related companies, and why
- Alterome TherapeuticsSimilar federal contract value in Biotech · null in contracts
- Outpace BioSimilar federal contract value in Biotech · null in contracts
- Chemomab Therapeutics Ltd.Similar federal contract value in Biotech · null in contracts
- Mosaic Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Resolve Therapeutics LLCSimilar federal contract value in Biotech · null in contracts
- Strategic Science & Technologies LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .